Qube Research & Technologies LTD Eli Lilly & CO Put Options Transaction History

Qube Research & Technologies LTD

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $30.8 Million - $38.3 Million	39,900 Added 72.68%	94,800 $84 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $43.1 Million - $54 Million	-59,400 Reduced 51.97%	54,900 $49.7 Million
Q1 2024 May 14, 2024	BUY	$592.2 - $792.28 $29.5 Million - $39.5 Million	49,800 Added 77.21%	114,300 $88.9 Million
Q4 2023 Feb 13, 2024	BUY	$525.19 - $619.13 $24.1 Million - $28.4 Million	45,900 Added 246.77%	64,500 $37.6 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $5.3 Million - $7.31 Million	12,200 Added 190.63%	18,600 $9.99 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $2.24 Million - $3 Million	6,400 New	6,400 $3 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $8.89 Million - $10.1 Million	30,000 New	30,000 $9.7 Million

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $760B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.